01.10.2018

ESMA Lists Venues Exempted From Open Access

01.10.2018

The European Securities and Markets Authority (ESMA) has published a list of those trading venues for which a temporary exemption from the open access provisions under 36(5) of the Markets in Financial Instruments Regulation (MiFIR) exists.

While MiFIR allows firms to freely choose where to trade and clear their products, which both CCPs and trading venues need to facilitate, trading venues and CCPs may notify ESMA and their national competent authority of their intention to temporarily opt-out from the access provisions for exchange-traded derivatives (ETDs) provided that certain conditions are met. Concerning trading venues for which the annual notional amount of ETDs traded on the venue falls below a certain threshold, the exemption must be approved by ESMA. The list published today provides the list of trading venues which have notified such intention to ESMA.

A similar provision exists for newly established CCPs that intend to temporarily opt-out from the access provisions in respect of transferable securities and money market instruments. However, at the time of publication ESMA has not received any notifications for such temporary exemption.

The list will be updated in case of any changes, including where an exemption is renewed.

Source: ESMA

Related articles

  1. Cboe is in the heart of the process for its strategic review as it changes its digital asset business.

  2. Basel Committee Consults on Interest-Rate Risk
    From The Markets

    CME Reports Record April ADV

    Interest rate average daily volume increased 37%, including record U.S. treasury options ADV.

  3. OCC Boosts Risk Management

    This enables EU regulators to extend the monitoring of derivative risk to digital assets.

  4. Daily Email Feature

    ICE Forms AI Centre of Excellence

    Investors are increasingly asking how ICE is incorporating artificial intelligence.

  5. Constructive Activist Funds Seek to Avoid Proxy Battles

    FMX Futures Exchange is due to launch in September this year to compete with CME Group.